These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6611586)

  • 1. The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation.
    Ottesen S; Stormorken H; Hatteland K
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):123-8. PubMed ID: 6611586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
    Stead SW
    Int J Clin Monit Comput; 1989 Dec; 6(4):247-54. PubMed ID: 2628513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of activated clotting time to monitor anticoagulation during cardiac surgery.
    Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV
    Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of activated coagulation time to monitor heparin during cardiac surgery.
    Roth JA; Cukingnan RA; Scott CR
    Ann Thorac Surg; 1979 Jul; 28(1):69-72. PubMed ID: 454047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
    Kaul TK; Crow MJ; Rajah SM; Deverall PB; Watson DA
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):95-102. PubMed ID: 449391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protamine dose assay in reversal of heparin following extracorporeal circulation for open heart surgery.
    Lee CN; Goh BL; Chin LG; Tan C; Woo M; Boey WK; Lee E; Kuah B
    Ann Acad Med Singap; 1990 Jan; 19(1):41-4. PubMed ID: 2327723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the activated coagulation time in cardiac surgery. Effects on heparin-protamine dosages and bleeding.
    Papaconstantinou C; Rådegran K
    Scand J Thorac Cardiovasc Surg; 1981; 15(2):213-5. PubMed ID: 7336191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery.
    Szalados JE; Ouriel K; Shapiro JR
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):515-8. PubMed ID: 7803739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery.
    Hendrice C; Schmartz D; Pradier O; Coron T; Kucharcezwski C; d'Hollander A; Capel P
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):245-9. PubMed ID: 7545449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real time measurement of heparin concentration during cardiopulmonary bypass.
    Hashimoto K; Sasaki T; Hachiya T; Takakura H; Onoguchi K; Nagahori R; Takeuchi S
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):645-51. PubMed ID: 10596996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.